These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 27047380)

  • 1. Quinoxaline 1,4-di-N-Oxides: Biological Activities and Mechanisms of Actions.
    Cheng G; Sa W; Cao C; Guo L; Hao H; Liu Z; Wang X; Yuan Z
    Front Pharmacol; 2016; 7():64. PubMed ID: 27047380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An appraisal on synthetic and pharmaceutical perspectives of quinoxaline 1,4-di-N-oxide scaffold.
    Agrawal N; Bhardwaj A
    Chem Biol Drug Des; 2022 Sep; 100(3):346-363. PubMed ID: 35610776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The critical role of oxidative stress in the toxicity and metabolism of quinoxaline 1,4-di-N-oxides in vitro and in vivo.
    Wang X; Martínez MA; Cheng G; Liu Z; Huang L; Dai M; Chen D; Martínez-Larrañaga MR; Anadón A; Yuan Z
    Drug Metab Rev; 2016 May; 48(2):159-82. PubMed ID: 27285897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic and Molecular Basis of the Antibacterial Action of Quinoxaline 1,4-Di-N-Oxides against Escherichia coli.
    Cheng G; Li B; Wang C; Zhang H; Liang G; Weng Z; Hao H; Wang X; Liu Z; Dai M; Wang Y; Yuan Z
    PLoS One; 2015; 10(8):e0136450. PubMed ID: 26296207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of Antibacterial Action of Quinoxaline 1,4-di-
    Xu F; Cheng G; Hao H; Wang Y; Wang X; Chen D; Peng D; Liu Z; Yuan Z; Dai M
    Front Microbiol; 2016; 7():1948. PubMed ID: 28018297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further investigations into the genotoxicity of quinoxaline-di-N-oxides and their primary metabolites.
    Liu Q; Zhang J; Luo X; Ihsan A; Liu X; Dai M; Cheng G; Hao H; Wang X; Yuan Z
    Food Chem Toxicol; 2016 Jul; 93():145-57. PubMed ID: 27170491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antimicrobial activities of animal-used quinoxaline 1,4-di-N-oxides against mycobacteria, mycoplasma and fungi.
    Zhao Y; Cheng G; Hao H; Pan Y; Liu Z; Dai M; Yuan Z
    BMC Vet Res; 2016 Sep; 12(1):186. PubMed ID: 27600955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinoxaline 1,4-dioxides as anticancer and hypoxia-selective drugs.
    Gali-Muhtasib HU; Haddadin MJ; Rahhal DN; Younes IH
    Oncol Rep; 2001; 8(3):679-84. PubMed ID: 11295102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological activity of esters of quinoxaline-7-carboxylate 1,4-di-N-oxide against E. histolytica and their analysis as potential thioredoxin reductase inhibitors.
    Soto-Sánchez J; Caro-Gómez LA; Paz-González AD; Marchat LA; Rivera G; Moo-Puc R; Arias DG; Ramírez-Moreno E
    Parasitol Res; 2020 Feb; 119(2):695-711. PubMed ID: 31907668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinoxaline 1,4-di-N-Oxide Derivatives: Are They Unselective or Selective Inhibitors?
    Rivera G
    Mini Rev Med Chem; 2022; 22(1):15-25. PubMed ID: 33573542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of quinoxaline and quinoxaline 1,4-di-N-oxides derivatives as potential antiparasitic agents.
    Soto-Sánchez J; Ospina-Villa JD
    Chem Biol Drug Des; 2021 Oct; 98(4):683-699. PubMed ID: 34289242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quinoxaline and quinoxaline-1,4-di-N-oxides: An emerging class of antimycobacterials.
    Keri RS; Pandule SS; Budagumpi S; Nagaraja BM
    Arch Pharm (Weinheim); 2018 May; 351(5):e1700325. PubMed ID: 29611626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabolism of carbadox, olaquindox, mequindox, quinocetone and cyadox: an overview.
    Liu ZY; Sun ZL
    Med Chem; 2013 Dec; 9(8):1017-27. PubMed ID: 23521002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in Metabolism and Metabolic Toxicology of Quinoxaline 1,4-Di-N-oxides.
    An H; Li Y; Li Y; Gong S; Zhu Y; Li X; Zhou S; Wu Y
    Chem Res Toxicol; 2024 Apr; 37(4):528-539. PubMed ID: 38507288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quinoxaline 1,4-dioxide: a versatile scaffold endowed with manifold activities.
    Carta A; Corona P; Loriga M
    Curr Med Chem; 2005; 12(19):2259-72. PubMed ID: 16178784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High risk of adrenal toxicity of N1-desoxy quinoxaline 1,4-dioxide derivatives and the protection of oligomeric proanthocyanidins (OPC) in the inhibition of the expression of aldosterone synthetase in H295R cells.
    Wang X; Yang C; Ihsan A; Luo X; Guo P; Cheng G; Dai M; Chen D; Liu Z; Yuan Z
    Toxicology; 2016 Feb; 341-343():1-16. PubMed ID: 26802905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotoxicity evaluation of Mequindox in different short-term tests.
    Ihsan A; Wang X; Tu HG; Zhang W; Dai MH; Peng DP; Wang YL; Huang LL; Chen DM; Mannan S; Tao YF; Liu ZL; Yuan ZH
    Food Chem Toxicol; 2013 Jan; 51():330-6. PubMed ID: 23063596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, Synthesis, and Biological Evaluation of Novel Thiazolidinone-Containing Quinoxaline-1,4-di-
    Zhang H; Zhang J; Qu W; Xie S; Huang L; Chen D; Tao Y; Liu Z; Pan Y; Yuan Z
    Front Chem; 2020; 8():598. PubMed ID: 32850634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quinoxaline 1,4-dioxides induce G2/M cell cycle arrest and apoptosis in human colon cancer cells.
    Gali-Muhtasib HU; Diab-Assaf M; Haddadin MJ
    Cancer Chemother Pharmacol; 2005 Apr; 55(4):369-378. PubMed ID: 15538569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quinoxaline 1,4-dioxides: hypoxia-selective therapeutic agents.
    Diab-Assef M; Haddadin MJ; Yared P; Assaad C; Gali-Muhtasib HU
    Mol Carcinog; 2002 Apr; 33(4):198-205. PubMed ID: 11933073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.